Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Results of the Brief Jail Mental Health Screen Across Repeated Jail Bookings.

Zottola SA, Desmarais SL, Neupert SD, Dong L, Laber E, Lowder EM, Van Dorn RA.

Psychiatr Serv. 2019 Aug 5:appips201800377. doi: 10.1176/appi.ps.201800377. [Epub ahead of print]

PMID:
31378191
2.

Methodological limitations in the measurement and statistical modeling of violence among adults with mental illness.

Johnson KL, Desmarais SL, Tueller SJ, Van Dorn RA.

Int J Methods Psychiatr Res. 2019 Feb 27:e1776. doi: 10.1002/mpr.1776. [Epub ahead of print]

PMID:
30810262
3.

Performance and clinical utility of a short violence risk screening tool in U.S. adults with mental illness.

Cartwright JK, Desmarais SL, Johnson KL, Van Dorn RA.

Psychol Serv. 2018 Nov;15(4):398-408. doi: 10.1037/ser0000183.

PMID:
30382735
4.

Lifetime Suicide-Related Behavior, Violent Victimization, and Behavioral Health Outcomes: Results From a Vulnerable Population Needs Assessment.

Cramer RJ, Johnson KL, Nobles MR, Holley SR, Desmarais SL, Gemberling TM, Wright S, Wilsey CN, Van Dorn RA.

J Interpers Violence. 2018 Sep 28:886260518801941. doi: 10.1177/0886260518801941. [Epub ahead of print]

PMID:
30261811
5.

Predictors of Posttraumatic Stress Disorder, Anxiety Disorders, Depressive Disorders, and Any Mental Health Condition Among U.S. Soldiers and Marines, 2001-2011.

Levin-Rector A, Hourani LL, Van Dorn RA, Bray RM, Stander VA, Cartwright JK, Morgan JK, Trudeau J, Lattimore PK.

J Trauma Stress. 2018 Aug;31(4):568-578. doi: 10.1002/jts.22316. Epub 2018 Jul 19.

PMID:
30025180
6.

Safety evaluation of xylanase 50316 enzyme preparation (also known as VR007), expressed in Pseudomonas fluorescens, intended for use in animal feed.

Van Dorn R, Shanahan D, Ciofalo V.

Regul Toxicol Pharmacol. 2018 Aug;97:48-56. doi: 10.1016/j.yrtph.2018.05.016. Epub 2018 May 29.

PMID:
29857114
7.

Trends in mental health outcomes and combat exposure among US marines returning from Iraq, Afghanistan or other deployments, 2004-13.

Morgan JK, Levin-Rector A, Van Dorn RA, Trudeau J, Hourani LL, Cartwright JK, Lattimore PK.

J Public Health (Oxf). 2019 Jun 1;41(2):313-320. doi: 10.1093/pubmed/fdy078.

PMID:
29733396
8.

Barriers and facilitators to implementing an evidence-based woman-focused intervention in South African health services.

Howard BN, Van Dorn R, Myers BJ, Zule WA, Browne FA, Carney T, Wechsberg WM.

BMC Health Serv Res. 2017 Nov 21;17(1):746. doi: 10.1186/s12913-017-2669-2.

9.

Jail-to-community treatment continuum for adults with co-occurring substance use and mental disorders: study protocol for a pilot randomized controlled trial.

Van Dorn RA, Desmarais SL, Rade CB, Burris EN, Cuddeback GS, Johnson KL, Tueller SJ, Comfort ML, Mueser KT.

Trials. 2017 Aug 4;18(1):365. doi: 10.1186/s13063-017-2088-z.

10.

Preventing and De-escalating Aggressive Behavior Among Adult Psychiatric Patients: A Systematic Review of the Evidence.

Gaynes BN, Brown CL, Lux LJ, Brownley KA, Van Dorn RA, Edlund MJ, Coker-Schwimmer E, Weber RP, Sheitman B, Zarzar T, Viswanathan M, Lohr KN.

Psychiatr Serv. 2017 Aug 1;68(8):819-831. doi: 10.1176/appi.ps.201600314. Epub 2017 Apr 17. Review.

PMID:
28412887
11.

Reliability and Validity of START and LSI-R Assessments in Mental Health Jail Diversion Clients.

Lowder EM, Desmarais SL, Rade CB, Johnson KL, Van Dorn RA.

Assessment. 2017 Apr 1:1073191117704505. doi: 10.1177/1073191117704505. [Epub ahead of print]

PMID:
28412837
12.

The intersection of interpersonal and self-directed violence among general adult, college student and sexually diverse samples.

Cramer RJ, Desmarais SL, Johnson KL, Gemberling TM, Nobles MR, Holley SR, Wright S, Van Dorn R.

Int J Soc Psychiatry. 2017 Feb;63(1):78-85. doi: 10.1177/0020764016683728. Epub 2016 Dec 13.

PMID:
28135995
13.

Leading indicators of community-based violent events among adults with mental illness.

Van Dorn RA, Grimm KJ, Desmarais SL, Tueller SJ, Johnson KL, Swartz MS.

Psychol Med. 2017 May;47(7):1179-1191. doi: 10.1017/S0033291716003160. Epub 2016 Dec 21.

PMID:
27998319
14.

Effects of sample size and distributional assumptions on competing models of the factor structure of the PANSS and BPRS.

Tueller SJ, Johnson KL, Grimm KJ, Desmarais SL, Sellers BG, Van Dorn RA.

Int J Methods Psychiatr Res. 2017 Dec;26(4). doi: 10.1002/mpr.1549. Epub 2016 Dec 2.

15.

A longitudinal analysis of the overlap between violence and victimization among adults with mental illnesses.

Johnson KL, Desmarais SL, Tueller SJ, Grimm KJ, Swartz MS, Van Dorn RA.

Psychiatry Res. 2016 Dec 30;246:203-210. doi: 10.1016/j.psychres.2016.09.039. Epub 2016 Sep 26.

16.

Visualization of Categorical Longitudinal and Times Series Data.

Tueller SJ, Van Dorn RA, Bobashev GV.

Methods Rep RTI Press. 2016 Feb;2016. pii: MR-0033-1602.

17.

Strategies To De-escalate Aggressive Behavior in Psychiatric Patients [Internet].

Gaynes BN, Brown C, Lux LJ, Brownley K, Van Dorn R, Edlund M, Coker-Schwimmer E, Zarzar T, Sheitman B, Weber RP, Viswanathan M, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jul.

18.

The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18.

Van Dorn RA, Desmarais SL, Grimm KJ, Tueller SJ, Johnson KL, Sellers BG, Swartz MS.

Psychiatry Res. 2016 Nov 30;245:83-90. doi: 10.1016/j.psychres.2016.08.029. Epub 2016 Aug 9.

19.

Proximal Risk Factors for Short-Term Community Violence Among Adults With Mental Illnesses.

Johnson KL, Desmarais SL, Grimm KJ, Tueller SJ, Swartz MS, Van Dorn RA.

Psychiatr Serv. 2016 Jul 1;67(7):771-8. doi: 10.1176/appi.ps.201500259. Epub 2016 Feb 29.

20.

Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data.

Tueller SJ, Deboeck PR, Van Dorn RA.

J Behav Med. 2016 Dec;39(6):969-980. doi: 10.1007/s10865-016-9727-9. Epub 2016 Feb 27.

21.

Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies.

Volavka J, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Czobor P.

Eur Psychiatry. 2016 Jan;31:13-9. doi: 10.1016/j.eurpsy.2015.10.003. Epub 2015 Dec 4.

22.

Mental health correlates of drug treatment among women who use methamphetamine.

Rade CB, Desmarais SL, Van Dorn RA, Lutnick A, Kral AH, Lorvick J.

Am J Addict. 2015 Oct;24(7):646-53. doi: 10.1111/ajad.12279. Epub 2015 Aug 24.

PMID:
26300389
23.

Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.

Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Volavka J.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1158-66. doi: 10.1016/j.euroneuro.2015.04.003. Epub 2015 Apr 30.

24.

Latent class analysis of discordance between results of drug use assessments in the CATIE data.

Johnson KL, Desmarais SL, Swartz MS, Van Dorn RA.

Schizophr Res. 2015 Feb;161(2-3):434-8. doi: 10.1016/j.schres.2014.11.016. Epub 2014 Dec 1.

25.

From Risk Assessment to Risk Management: Matching Interventions to Adolescent Offenders' Strengths and Vulnerabilities.

Singh JP, Desmarais SL, Sellers BG, Hylton T, Tirotti M, Van Dorn RA.

Child Youth Serv Rev. 2014 Dec 1;47(Pt 1):1-9.

26.

Treatment participation and medication adherence: effects on criminal justice costs of persons with mental illness.

Robertson AG, Swanson JW, Van Dorn RA, Swartz MS.

Psychiatr Serv. 2014 Oct;65(10):1189-91. doi: 10.1176/appi.ps.201400247.

PMID:
25270494
27.

Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study - ADDENDUM.

Volavka J, Czobor P, Citrome L, Van Dorn RA.

CNS Spectr. 2014 Oct;19(5):466. doi: 10.1017/S1092852914000364. Epub 2014 Jul 14. No abstract available.

PMID:
25017569
28.

A typology of community violence perpetration and victimization among adults with mental illnesses.

Johnson KL, Desmarais SL, Van Dorn RA, Grimm KJ.

J Interpers Violence. 2015 Feb;30(3):522-40. doi: 10.1177/0886260514535102. Epub 2014 Jun 11.

29.

Community violence perpetration and victimization among adults with mental illnesses.

Desmarais SL, Van Dorn RA, Johnson KL, Grimm KJ, Douglas KS, Swartz MS.

Am J Public Health. 2014 Dec;104(12):2342-9. doi: 10.2105/AJPH.2013.301680. Epub 2014 Feb 13.

30.

Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.

Volavka J, Czobor P, Citrome L, Van Dorn RA.

CNS Spectr. 2014 Oct;19(5):374-81. doi: 10.1017/S1092852913000849. Epub 2013 Nov 28. Erratum in: CNS Spectr. 2014 Oct;19(5):466.

31.

Letter to the editor: Critique of Bahorik et al. (2013)--'Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors'.

Van Dorn RA, Desmarais SL, Swartz MS, Young MS, Sellers BG.

Psychol Med. 2014 Feb;44(3):668-70. doi: 10.1017/S0033291713002511. Epub 2013 Oct 28. No abstract available.

32.

Risk factors for early readmission to acute care for persons with schizophrenia taking antipsychotic medications.

Boaz TL, Becker MA, Andel R, Van Dorn RA, Choi J, Sikirica M.

Psychiatr Serv. 2013 Dec 1;64(12):1225-9. doi: 10.1176/appi.ps.003382012.

PMID:
23945797
33.

The cost of assisted outpatient treatment: can it save states money?

Swanson JW, Van Dorn RA, Swartz MS, Robbins PC, Steadman HJ, McGuire TG, Monahan J.

Am J Psychiatry. 2013 Dec;170(12):1423-32. doi: 10.1176/appi.ajp.2013.12091152. Erratum in: Am J Psychiatry. 2013 Dec 1;170(12):1499. Am J Psychiatry. 2013 Oct 1;170(10):1218.

PMID:
23896998
34.

Drug and alcohol trajectories among adults with schizophrenia: data from the CATIE study.

Van Dorn RA, Desmarais SL, Tueller SJ, Jolley JM, Johnson KL, Swartz MS.

Schizophr Res. 2013 Aug;148(1-3):126-9. doi: 10.1016/j.schres.2013.05.006. Epub 2013 May 29.

35.

Effects of outpatient treatment on risk of arrest of adults with serious mental illness and associated costs.

Van Dorn RA, Desmarais SL, Petrila J, Haynes D, Singh JP.

Psychiatr Serv. 2013 Sep 1;64(9):856-62. doi: 10.1176/appi.ps.201200406.

PMID:
23677480
36.

Measurement of predictive validity in violence risk assessment studies: a second-order systematic review.

Singh JP, Desmarais SL, Van Dorn RA.

Behav Sci Law. 2013 Jan-Feb;31(1):55-73. doi: 10.1002/bsl.2053. Review.

PMID:
23444299
37.

Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies.

Witt K, van Dorn R, Fazel S.

PLoS One. 2013;8(2):e55942. doi: 10.1371/journal.pone.0055942. Epub 2013 Feb 13. Review. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/f4abfc20-5a38-4dec-aa46-7d28018bbe38.

38.

Accuracy of self-report, biological tests, collateral reports and clinician ratings in identifying substance use disorders among adults with schizophrenia.

Desmarais SL, Van Dorn RA, Sellers BG, Young MS, Swartz MS.

Psychol Addict Behav. 2013 Sep;27(3):774-87. doi: 10.1037/a0031256. Epub 2012 Dec 31.

39.

A meta-analysis of the Val158Met COMT polymorphism and violent behavior in schizophrenia.

Singh JP, Volavka J, Czobor P, Van Dorn RA.

PLoS One. 2012;7(8):e43423. doi: 10.1371/journal.pone.0043423. Epub 2012 Aug 14.

40.

Characteristics of START assessments completed in mental health jail diversion programs.

Desmarais SL, Van Dorn RA, Telford RP, Petrila J, Coffey T.

Behav Sci Law. 2012 Jul-Aug;30(4):448-69. doi: 10.1002/bsl.2022. Epub 2012 Jul 17.

PMID:
22807034
41.

Assessing illicit drug use among adults with schizophrenia.

Van Dorn RA, Desmarais SL, Scott Young M, Sellers BG, Swartz MS.

Psychiatry Res. 2012 Dec 30;200(2-3):228-36. doi: 10.1016/j.psychres.2012.05.028. Epub 2012 Jul 15.

42.

Ethnicity and cultural issues.

Zeber JE, Gonzalez JM, Van Dorn R, Interian A.

Depress Res Treat. 2011;2011:195084. doi: 10.1155/2011/195084. Epub 2011 Oct 30. No abstract available.

43.

Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.

Van Dorn RA, Andel R, Boaz TL, Desmarais SL, Chandler K, Becker MA, Howe A.

J Clin Psychiatry. 2011 Apr;72(4):502-8. doi: 10.4088/JCP.10m06618.

PMID:
21527125
44.

Mental disorder and violence: is there a relationship beyond substance use?

Van Dorn R, Volavka J, Johnson N.

Soc Psychiatry Psychiatr Epidemiol. 2012 Mar;47(3):487-503. doi: 10.1007/s00127-011-0356-x. Epub 2011 Feb 26.

PMID:
21359532
45.

Changes in guideline-recommended medication possession after implementing Kendra's law in New York.

Busch AB, Wilder CM, Van Dorn RA, Swartz MS, Swanson JW.

Psychiatr Serv. 2010 Oct;61(10):1000-5. doi: 10.1176/ps.2010.61.10.1000.

46.

Reductions in arrest under assisted outpatient treatment in New York.

Gilbert AR, Moser LL, Van Dorn RA, Swanson JW, Wilder CM, Robbins PC, Keator KJ, Steadman HJ, Swartz MS.

Psychiatr Serv. 2010 Oct;61(10):996-9. doi: 10.1176/ps.2010.61.10.996.

PMID:
20889637
47.

Robbing Peter to pay Paul: did New York State's outpatient commitment program crowd out voluntary service recipients?

Swanson JW, Van Dorn RA, Swartz MS, Cislo AM, Wilder CM, Moser LL, Gilbert AR, McGuire TG.

Psychiatr Serv. 2010 Oct;61(10):988-95. doi: 10.1176/ps.2010.61.10.988.

PMID:
20889636
48.

Continuing medication and hospitalization outcomes after assisted outpatient treatment in New York.

Van Dorn RA, Swanson JW, Swartz MS, Wilder CM, Moser LL, Gilbert AR, Cislo AM, Robbins PC.

Psychiatr Serv. 2010 Oct;61(10):982-7. doi: 10.1176/ps.2010.61.10.982.

PMID:
20889635
49.

Assessing outcomes for consumers in New York's assisted outpatient treatment program.

Swartz MS, Wilder CM, Swanson JW, Van Dorn RA, Robbins PC, Steadman HJ, Moser LL, Gilbert AR, Monahan J.

Psychiatr Serv. 2010 Oct;61(10):976-81. doi: 10.1176/ps.2010.61.10.976.

PMID:
20889634
50.

Child Maltreatment and Delinquency Onset Among African American Adolescent Males.

Williams JH, Van Dorn RA, Bright CL, Jonson-Reid M, Nebbitt VE.

Res Soc Work Pract. 2010 May 1;20(3):253-259.

Supplemental Content

Loading ...
Support Center